ada glp-1 '26: Lilly's dominance, Pfizer's 'foundational' drug and Roche's 'me-too' option GLP-1 Drugs 2026: ADA Sessions

According to the Pblico newspaper , they are prescribed by doctors who do not work with diabetes patients, and are highly sought after by dieters, athletes, influencers, and even for use on animals

Diabetes 53: 13261335, 2004

Limited data exists about the impact beyond weight loss when GLP-1s are used in patients without a diagnosis of diabetes

Current perspectives: obesity and neurodegenerationlinks and risks

After 180 days, the primary outcome which included time to death, time to rehospitalization for heart failure, and time-averaged proportional change in NT-proBNP levels from baseline was not different between groups

"It's not a picture of you," says Michelle, who likes to compare the 3D images side by side when she takes a new one, which is every two weeks